5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators | Patent Number 11014917

US 11014917 B2
Application Number16890331
Publication NumberUS 20200291004 A1
Pendency11 months, 27 days
Filled DateJun 2, 2020
Priority DateAug 21, 2017
Publication DateSep 17, 2020
Expiration DateAug 20, 2037
Inventor/ApplicantsGee-Hong Kuo
Micheal Gaul
Guozhang Xu
ExaminesSEAMAN, D MARGARET M
Art Unit1625
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.